We are live on
!
Find out more
PDLI
PDL BioPharma, Inc.
PDLI
PDLI
Delisted
PDLI was delisted on the 30th of December, 2020.
154 hedge funds and large institutions have $347M invested in PDL BioPharma, Inc. in 2018 Q4 according to their latest regulatory filings, with 24 funds opening new positions, 31 increasing their positions, 63 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
196% more call options, than puts
Call options by funds: $148K | Put options by funds: $50K
20% more first-time investments, than exits
New positions opened: 24 | Existing positions closed: 20
5% more capital invested
Capital invested by funds: $329M → $347M (+$17.6M)
1% more funds holding
Funds holding: 152 → 154 (+2)
51% less repeat investments, than reductions
Existing positions increased: 31 | Existing positions reduced: 63
Holders
154
Holders Change
+2
Holders Change %
+1.32%
% of All Funds
3.43%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
24
Increased
31
Reduced
63
Closed
20
Calls
$148K
Puts
$50K
Net Calls
+$98K
Net Calls Change
-$178K
Top Buyers
| 1 |
BIP
Brandes Investment Partners
La Jolla,
California
|
+$1.45M |
| 2 |
Prudential Financial
Newark,
New Jersey
|
+$1.28M |
| 3 |
RC
RBF Capital
San Francisco,
California
|
+$1.15M |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$891K |
| 5 |
Citigroup
New York
|
+$857K |
Top Sellers
| 1 |
AC
Armistice Capital
New York
|
-$4.73M |
| 2 |
State Street
Boston,
Massachusetts
|
-$2.93M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$2.44M |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$2.14M |
| 5 |
AQR Capital Management
Greenwich,
Connecticut
|
-$1.74M |
